General Info

I'm a neurologist with subspecialty training in the diagnosis and treatment of multiple sclerosis (MS) and related disorders. My current positions are chair of the Department of Neurology, director of the Neuroscience Research Institute, director of the Multiple Sclerosis and Neuroimmunology Center, and co-director of the Neurological Institute at The Ohio State University Wexner Medical Center. I also hold the Stanley D. and Joan H. Ross Chair of Neuromodulatio y mission as an MS physician is to provide an accurate diagnosis and a highly personalized treatment plan for each patient. MS is a complex disease that affects each individual in unique ways. At the Ohio State Multiple Sclerosis and Neuroimmunology Center, we strive to alleviate symptoms and neurological deficits, prevent relapses, block new lesion formation in the brain and spinal cord, and slow or halt neurological decline using the latest medical research and cutting-edge therapies. Our ultimate goal is to improve our patients' quality of life and position them for the best long-term outcome possibl y research on MS and neuroimmunology has been published in high-impact journals and featured at academic meetings internationally. Our research is supported by annual funding from the National Institutes of Health (NIH) in excess of $ million. We've discovered that the type of inflammation that causes damage to the nervous system during MS can vary between individuals, suggesting that prescribed medicines must be customized for each patient. Active research projects are focused on understanding how the immune system and the central nervous system interact, and explaining their role in disease progression, remission and potential repair of neurological damage. I'm also investigating how we can use blood and spinal cord fluid samples from patients to better predict how an individual's disease might progress and what therapies could be most effectiv 've been on the "Best Doctors in America"